EXPERIMENTAL DRUGS / POTENTIAL ANTIBIOTIC THERAPIES AGAINST M. ULCERANS	TARGET PROTEIN													
Clarithromycin	23S rRNA on the 50s ribosomal subunit													
Rifampicin	RNA synthesis through interfering with bacterial RNA-polymerase													
Streptomycin	hinders formyl-methionyl-tRNA to bind with bacterial ribosomal 30S subunit													
Rifabutin	RNA synthesis through interfering with bacterial RNA-polymerase													
Amikacin	"formyl-methionyl-tRNA 

"													
Azithromycin														
Ethambutol														
Isoniazid (isonicotinic acid hydrazide [INH])														
Kanamycin														
Erythromycin														
Roxithromycin														
Linezolid														
Posizolid														
Sutezolid														
"TB47 (pyrazolo[1,5-a]pyridine-3-carboxamides)"	QcrB Cytochrome bc1:aa3													
P218	The enzyme dihydrofolate reductase (DHFR)													
Ciprofloxacin	DNA gyrase-catalyzed super-coiling of double-stranded DNA													
Sitafloxacin	Bacterial DNA gyrase (topoisomerase II)													
Moxifloxacin	DNA gyrase													
Ofloxacin	DNA gyrase													
Prulifloxacin	DNA gyrase													
Sparfloxacin	DNA gyrase													
Dapsone														
Rifalazil														
Epiroprim														
Ivermectins														
Milbemycin oxime and selamectin														
Imidazopyridine amine telacebec (Q203)	respiratory terminal oxidase cytochrome bc1:aa3													
"Moxifloxacin, R207910 and linezolid"	topoisomerase II (DNA gyrase) and topoisomerase IV													
Q203 (Telacebec)	cytochrome bcc-aa3 terminal oxidase													
Clofazimine														
Bedaquiline														
Rifapentine														
Pretomanid (PA-824)														
Mathesia